Clinical Trial

Study To Investigate The Potential DDI Between HEC585 And Pirfenidone/Nintedanib In Healthy Subjects

Name: Study To Investigate The Potential DDI Between HEC585 And Pirfenidone/Nintedanib In Healthy Subjects — clinical trial record (NCT07588646)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

A single-center, open-label study designed to assess the drug-drug interaction of HEC585 and pirfenidone in healthy male and female subjects. A single-center, open-label study designed to assess the drug-drug interaction of HEC585 and nintedanib in healthy male subjects.

Trial Details

NCT Number	NCT07588646
Lead Sponsor	Sunshine Lake Pharma Co., Ltd.
Conditions	Idiopathic Pulmonary Fibrosis
Enrollment	33 participants
Start Date	2021-06-29
Primary Completion	2021-11-30 (estimated)
Study Completion	2021-11-30 (estimated)
Updated on ClinicalTrials.gov	2026-05-15